Drug interactions
Bevacizumab + Lisocabtagene maraleucel
Severity: Minor
Bevacizumab and Lisocabtagene maraleucel: minor interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Bevacizumab has little immunosuppressive activity, so a true additive infection risk with CAR-T therapy is not established. Its bleeding and wound-healing effects may be relevant during cytopenias.
What this interaction means in plain words
Bevacizumab and Lisocabtagene maraleucel have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.
Bevacizumab belongs to Oncology; Lisocabtagene maraleucel belongs to Oncology.
Why it happens
No established immunologic mechanism for interaction.
What to do
No specific restriction is needed. Monitor for infection, bleeding and cytopenias after CAR-T infusion.
What to ask your pharmacist
- Is there anything I should notice while taking both?
- Do I need to tell my doctor at the next visit?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Bevacizumab and Lisocabtagene maraleucel, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Bevacizumab
- Bevacizumab + Sunitinib Major
- Bevacizumab + Daunorubicin Moderate
- Bevacizumab + Dengue vaccine Moderate
- Bevacizumab + Doxorubicin Moderate
- Bevacizumab + Doxorubicin liposomal Moderate
- Bevacizumab + Efgartigimod / hyaluronidase sc Moderate
Other interactions of Lisocabtagene maraleucel
Frequently asked questions
Can I take Bevacizumab with Lisocabtagene maraleucel?
MediHelp rates the interaction as minor. Bevacizumab and Lisocabtagene maraleucel have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Bevacizumab has little immunosuppressive activity, so a true additive infection risk with CAR-T therapy is not established. Its bleeding and wound-healing effects may be relevant during cytopenias.
How serious is the interaction between Bevacizumab and Lisocabtagene maraleucel?
MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No specific restriction is needed. Monitor for infection, bleeding and cytopenias after CAR-T infusion.
What other medicines interact with Bevacizumab?
MediHelp also lists interactions of Bevacizumab with, for example, Sunitinib, Daunorubicin, Dengue vaccine. The full list is on the Bevacizumab page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
